Assenagon Asset Management S.A. Ovid Therapeutics Inc. Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
A detailed history of Assenagon Asset Management S.A. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 924,576 shares of OVID stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
924,576
Previous 435,620
112.24%
Holding current value
$1.45 Million
Previous $143,000
727.27%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OVID
# of Institutions
73Shares Held
33.2MCall Options Held
15.6KPut Options Held
0-
Black Rock Inc. New York, NY3.99MShares$6.27 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$6.05 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.64MShares$4.14 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$3.5 Million0.35% of portfolio
-
Acadian Asset Management LLC Boston, MA2.11MShares$3.31 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $111M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...